You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
Colorcon
Express Scripts
Baxter
McKesson

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

LORATADINE AND PSEUDOEPHEDRINE SULFATE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Loratadine And Pseudoephedrine Sulfate, and what generic alternatives are available?

Loratadine And Pseudoephedrine Sulfate is a drug marketed by Heritage Pharma, P And L, Perrigo Pharma Intl, and Sun Pharm Inds Ltd. and is included in five NDAs.

The generic ingredient in LORATADINE AND PSEUDOEPHEDRINE SULFATE is loratadine; pseudoephedrine sulfate. There are thirty-nine drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the loratadine; pseudoephedrine sulfate profile page.

Summary for LORATADINE AND PSEUDOEPHEDRINE SULFATE
Drug patent expirations by year for LORATADINE AND PSEUDOEPHEDRINE SULFATE
Recent Clinical Trials for LORATADINE AND PSEUDOEPHEDRINE SULFATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
BayerPhase 1
BayerPhase 4
Azidus BrasilPhase 3

See all LORATADINE AND PSEUDOEPHEDRINE SULFATE clinical trials

US Patents and Regulatory Information for LORATADINE AND PSEUDOEPHEDRINE SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Heritage Pharma LORATADINE AND PSEUDOEPHEDRINE SULFATE loratadine; pseudoephedrine sulfate TABLET, EXTENDED RELEASE;ORAL 076208-001 Jan 28, 2004 DISCN No No   Start Trial   Start Trial   Start Trial
Perrigo Pharma Intl LORATADINE AND PSEUDOEPHEDRINE SULFATE loratadine; pseudoephedrine sulfate TABLET, EXTENDED RELEASE;ORAL 075989-001 Mar 4, 2004 OTC No No   Start Trial   Start Trial   Start Trial
P And L LORATADINE AND PSEUDOEPHEDRINE SULFATE loratadine; pseudoephedrine sulfate TABLET, EXTENDED RELEASE;ORAL 075706-001 Feb 21, 2003 OTC No No   Start Trial   Start Trial   Start Trial
Perrigo Pharma Intl LORATADINE AND PSEUDOEPHEDRINE SULFATE loratadine; pseudoephedrine sulfate TABLET, EXTENDED RELEASE;ORAL 076050-001 Jan 30, 2003 OTC No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
McKesson
Colorcon
Harvard Business School
Mallinckrodt
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.